Cancer Immunotherapy Market
Cancer immunotherapy is a type of treatment that harnesses the body’s immune system to recognize and attack cancer cells. It works by stimulating immune responses or enhancing the ability of immune cells to target tumors. This approach includes methods like checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. Unlike traditional therapies, it aims for long-lasting immunity and specificity against cancer cells.
Download Sample PDF Copy https://www.theinsightpartners.com/sample/TIPRE00006688/?utm_source=OpenPR&utm_medium=10826
The List of Companies
• F. Hoffmann-La Roche AG
• Advaxis Inc.
• Merck & Co., Inc.
• Eli Lilly and Company
• Bristol-Myers Squibb Company
• Pfizer Inc.
• Novartis AG
• Bayer AG
• Immunomedics Inc.
Contact US
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
This release was published on openPR.